Francis Barany
Francis Barany - Cancer Diagnostics and Drug Discovery
Working at Weill Cornell Medicine in New York City, Francis Barany is a professor of microbiology and immunology. His laboratory focuses on developing new therapeutics, advancing precision diagnostics, and studying cancer biology. In addition, his work centers on translational science, the process of moving laboratory discoveries toward patient-focused applications. As an educator, Francis Barany teaches medical and graduate students and works with postdoctoral researchers.
Mr. Barany’s team studies molecular profiles, including the patterns of DNA, RNA, and epigenetic changes found in tumors. The group also investigates liquid biopsy methods that analyze blood for cancer-associated molecular signals. These research efforts seek scalable approaches to cancer screening and monitoring that could contribute to lower-cost care, but they still require clinical validation.
His contributions to the industry include ligase chain reaction and ligase detection reaction technologies. These methods use DNA-joining enzymes to identify genetic variation in samples. He has also contributed to CURE-PROs, a preclinical class of paired small molecules designed to self-assemble inside cells. The resulting compounds bring a selected protein near an E3 ligase, an enzyme that tags proteins for cellular recycling. CURE-PRO research has not established human efficacy.
The recipient of a PhD in microbiology from the Rockefeller University, Mr. Barany also holds a bachelor’s degree in chemistry from the University of Illinois. His publications can be explored through PubMed, and official patent records are searchable through the USPTO Patent Public Search.
Other Media
Contact
New York, NY US